SCHEMBL8807918

SCHEMBL8807918

CCCCc1nc(Cl)c(CC(=O)O)c(Cc2ccc(C(=O)OC(C)(C)C)cc2)n1

nearest known ligand 0.40

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 2/20 0.40
AGTR2 P50052 2/20 0.40
ALDH1A1 P00352 2/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
SMO Q99835 1/20 0.35
CTRC Q99895 1/20 0.35
PTGS1 P23219 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35
RHEB Q15382 1/20 0.35
PDE4B Q07343 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL9250689 0.90 AGTR1 (0.34) AGTR1AGTR2SMOCTRCPTGS1
SCHEMBL9250685 0.90 SMO (0.34) AGTR1AGTR2SMOPTGS1
SCHEMBL8806788 0.89 AGTR1 (0.42) AGTR1AGTR2ALDH1A1HPGDHSD17B10
SCHEMBL1228189 0.87 AGTR1 (0.53) AGTR1AGTR2ALDH1A1HPGDHSD17B10
SCHEMBL8808929 0.83 ALDH1A1 (0.41) AGTR1AGTR2ALDH1A1HPGDHSD17B10
Acetic Acid SCHEMBL9250323 0.79 DHFR (0.44) AGTR1AGTR2
SCHEMBL9250317 0.78 DHFR (0.40) ALDH1A1
SCHEMBL9254231 0.78 AGTR1 (0.44) AGTR1AGTR2CTRC
SCHEMBL8806775 0.77 AGTR1 (0.56) AGTR1AGTR2
Acetic Acid SCHEMBL9254240 0.76 AGTR1 (0.45) AGTR1AGTR2ALDH1A1CTRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0515265-B1 Pyrimidin derivatives, process for their preparation, the obtained intermediates, their use as medicines and the pharmaceutical compositions containing them ROUSSEL UCLAF (FR) 1997-04-16 EP disclosed
EP-0515265-A1 Pyrimidin derivates, process for their preparation, the obtained intermediates, their use as medicines and the pharmaceutical compositions containing them ROUSSEL UCLAF (FR) 1992-11-25 EP disclosed